Cell Culture Reagents Market size was over USD 5.27 billion in 2023 and is poised to reach USD 24.94 billion by the end of 2036, growing at around 12.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of cell culture reagents is assessed at USD 5.81 billion.
Extensive research associated with various diseases and treatments in western countries, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing research in vaccine development and rising research in stem cell technology. It indicates there is a need of vaccine development. Moreover, the market for cell culture reagents is mainly driven by biotechnology sector. Increasing awareness about stem cell culture is likely to be major factor for cell culture reagents market. In addition, cell culture reagents are also used in medicine, microbiology, agriculture, pharmaceuticals, food additives and cosmetics. Increasing demand for advanced technologies from biopharmaceuticals is likely to provide opportunities for cell culture reagents market in near future. The growth of the market can be attributed to the fact that cell culture reagents play a key role in cell-based products, manufacturing and testing of pharmaceutical drug products, and several other healthcare-related solutions. Technological advancements in pharmaceutical and biotechnology sector are expected to be major drivers for the market. However, threats from the substitutes and higher prices can be major restraint for the market.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
12.7% |
|
Base Year Market Size (2023) |
USD 5.27 billion |
|
Forecast Year Market Size (2036) |
USD 24.94 billion |
|
Regional Scope |
|
The cell culture reagents market is segmented based on reagent type into media, sera, culture, and others, out of which, the culture segment is anticipated to grab the largest share by the end of 2021. The primary reason behind the major share of culture segment is the application of mammalian cell cultures in the production of mammalian pharmaceuticals and the growing demand for non-conventional drugs developed as a result of bio-production of proteomically and genetically enhanced drugs. This segment is expected to witness lucrative growth in demand over the forecast period.
On the basis of application, the biopharmaceutical manufacturing segment in the global cell culture reagents market is projected to grow with a significant CAGR over the forecast period. This segment's high growth is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and an increase in the demand for monoclonal antibodies (mAbs).
Our in-depth analysis of the global market includes the following segments
|
By Reagent Type |
|
|
By Applications |
|
APAC Market Statistics
Geographically, the cell culture reagents market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is likely to account for largest revenue share by 2036, owing to increasing demand for cell culture media and rise in biopharmaceutical research.
North America Market Analysis
Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue. The growing regulatory approvals for cell culture-based vaccines, growing academic and government investments in cell-based research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are driving the cell culture market in the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?